World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
127
Citations
69827
World Ranking
261
National Ranking
169

Medicine

D-Index
127
Citations
69956
World Ranking
2805
National Ranking
1565

Overview

Michael T. Lotze is affiliated with the University of Pittsburgh in the United States. Their research spans multiple fields, focusing primarily on medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology.

Their work concentrates on several subfields, including oncology, immunology, molecular biology, pulmonary and respiratory medicine, and cancer research. The main topics covered by their publications include cancer immunotherapy and biomarkers, pancreatic and hepatic oncology research, CAR-T cell therapy research, immunotherapy and immune responses, immune cell function and interaction, cancer genomics and diagnostics, and autophagy in disease and therapy.

Michael T. Lotze has contributed to various notable publication venues. Frequent venues for their research include Journal for ImmunoTherapy of Cancer, Regular and Young Investigator Award Abstracts, Journal of Clinical Oncology, Frontiers in Immunology, and Annals of Surgical Oncology.

Their research collaborations are reflected in frequent co-authorships with several scholars. These include Pranav Murthy, Herbert J. Zeh, Aatur D. Singhi, Amer H. Zureikat, and Daolin Tang.

Selected recent papers by Michael T. Lotze represent a range of topics and publication years:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, 2020, Journal for ImmunoTherapy of Cancer
  • The multifunctional protein HMGB1: 50 years of discovery, 2023, Nature Reviews. Immunology
  • A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients, 2020, Clinical Cancer Research
  • A guideline on the molecular ecosystem regulating ferroptosis, 2024, Nature Cell Biology
  • HMGB1 as a potential biomarker and therapeutic target for severe COVID-19, 2020, Heliyon

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • The Beclin 1 network regulates autophagy and apoptosis

    R Kang;H J Zeh;M T Lotze;D Tang

  • The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

    Allan Tsung;Rohit Sahai;Hiroyuki Tanaka;Atsunori Nakao

  • Interleukin-17 promotes angiogenesis and tumor growth.

    Muneo Numasaki;Jun Ichi Fukushi;Mayumi Ono;Satwant K. Narula

  • Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

    L. Zitvogel;J. I. Mayordomo;Tjendimin Tjandrawan;A. B. Deleo

  • PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity

    Daolin Tang;Rui Kang;Carolyn B. Coyne;Herbert J. Zeh

  • Endogenous HMGB1 regulates autophagy

    Daolin Tang;Rui Kang;Kristen M. Livesey;Chun-Wei Cheh

  • Principles and current strategies for targeting autophagy for cancer treatment.

    Ravi K. Amaravadi;Jennifer Lippincott-Schwartz;Xiao Ming Yin;William A. Weiss

  • Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

    Christina M. Celluzzi;Jose I. Mayordomo;Walter J. Storkus;Michael T. Lotze

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox.

    Anna Rubartelli;Michael T. Lotze

  • Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

    Michael B. Atkins;Michael J. Robertson;Michael Gordon;Michael T. Lotze

  • Interleukin-12: biological properties and clinical application.

    Michele Del Vecchio;Emilio Bajetta;Stefania Canova;Michael T. Lotze

  • AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc- Activity.

    Xinxin Song;Xinxin Song;Shan Zhu;Pan Chen;Wen Hou

  • Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma

    Lowell A. Goldsmith;Frederic B. Askin;Alfred E. Chang;Cynthia Cohen

  • IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.

    Muneo Numasaki;Mika Watanabe;Takashi Suzuki;Hidenori Takahashi

  • The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

    Kirk D. Denicoff;David R. Rubinow;Moshe Z. Papa;Colleen Simpson

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

Frequent Co-Authors

Herbert J. Zeh
Herbert J. Zeh The University of Texas Southwestern Medical Center
Daolin Tang
Daolin Tang The University of Texas Southwestern Medical Center
Walter J. Storkus
Walter J. Storkus University of Pittsburgh
Rui Kang
Rui Kang University of Pittsburgh
Hideaki Tahara
Hideaki Tahara University of Tokyo
Paul D. Robbins
Paul D. Robbins University of Minnesota
Timothy R. Billiar
Timothy R. Billiar University of Pittsburgh
Michael R. Shurin
Michael R. Shurin University of Pittsburgh
Theresa L. Whiteside
Theresa L. Whiteside University of Pittsburgh
Pawel Kalinski
Pawel Kalinski Roswell Park Comprehensive Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing is a popular pathway, with various online programs designed to fit different backgrounds and schedules. For example, students looking for a fast-track option may consider accelerated nurse practitioner programs, which prepare graduates for advanced clinical roles in a shorter time frame.

Beginners without prior nursing experience can pursue foundational studies through the best online BSN programs for non nurses. These programs provide essential nursing education remotely, making them accessible while maintaining quality.

For those seeking easier admission routes, it’s worth exploring the easiest accelerated nursing programs to get into. Such programs offer a manageable entry process without compromising critical nursing skills necessary for a healthcare career.

Additionally, aspiring practical nurses may find valuable options through LPN schools easy to get into. These provide practical nursing education quickly, serving as a stepping stone to more advanced healthcare roles.

Connecting immunology knowledge with these nursing pathways can enhance career flexibility and impact within healthcare settings.

Best Scientists Citing Michael T. Lotze

Trending Scientists

Recently Published Articles